Safety and Efficacy of KER-065 in Participants With Duchenne Muscular Dystrophy (opens ClinicalTrials.gov)
- Sponsor
- Keros Therapeutics, Inc.
- Enrolment
- 36
- Started
- 2026-09-25
- Last update
- 2026-11-04
Conditions: Duchenne Muscular Dystrophy
Interventions: KER-065